Reach Us +441414719275
Hepatorenal Protection Inrenal Ischemia/reperfusion By Celecoxib And Pentoxifylline | 69984

Journal of Neuroscience and Neuropharmacology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Hepatorenal protection inrenal ischemia/reperfusion by celecoxib and pentoxifylline

7th Global Experts Meeting on NEUROPHARMACOLOGY

Asmaa A Khalifa, Mahmoud M Farag, Wessam F Elhadidy and Radwa M Rashad

Alexandria University, Egypt

Posters & Accepted Abstracts: Neurochem Neuropharm

DOI: 10.4172/2469-9780-C1-006

Renal ischemia/reperfusion (I/R) is a major clinical problem. Its pathogenesis is multifactorial involving oxidative stress, cytokine overproduction, and inflammatory responses in the kidney and remote organs. This study was performed to evaluate the effects of celecoxib (CEB) and pentoxifylline (PTX) on kidney and liver changes after renal I/R in rats. Renal ischemia was induced by clamping renal pedicles for 1h followed by reperfusion for another 1 h. The rats were assigned to five groups: sham control, untreated I/R, CEB + I/R, PTX + I/R, and (CEB + PTX)+I/R. Drug treatment was given for 7 d before I/R. Serum and tissue biochemical and histomorphologic changes were evaluated after reperfusion. Renal I/R caused changes in kidney and liver histology with a significant reduction in the function of both organs. An increase in tumor necrosis factor-alpha, myeloperoxidase, and malondialdehyde levels with a decrease in glutathione content and superoxide dismutase activity was observed in kidney and liver tissues. Pretreatment with CEB, PTX, or CEB + PTX attenuated all these changes and the extent of improvement was similar in all drug-treated groups. Finally, this study is the first experimental work demonstrating the simultaneous nephroprotective and hepatoprotective effects of CEB and PTX after renal I/R. It seems likely that both drugs protect the kidney and liver by reducing oxidative stress, attenuating tumor necrosis factor-alpha production and inhibiting neutrophil tissue infiltration. No additive protective effects were observed in rats received the combined treatment. Thus, our results may imply a promising therapeutic approach by using CEB or PTX to protect the kidney and liver against the hazardous consequences of renal I/R. Moreover Hepatorenal ischemia may have a negative impact on the brain as one of the affected distant organs which requires further investigations.

Asmaa A Khalifa has worked as Lecturer Assistant at Pharos University at Alexandria (PUA), Egypt. She is also a PhD student at the Medical Research Institute Alexandria University. She has worked on the topic of Ischemia for more than 2 years and continues to explore this field not only in the liver and kidney but also in heart, brain and other organs throughout the body as the problem of ischemia can affect many distant organs.

Email: [email protected]